Senate Opposition • 25%

Public Criticism • 25%

Internal FDA Resistance • 25%

Healthcare Industry Pushback • 25%

Funding constraints • 25%

Technological hurdles • 25%

Political opposition • 25%

International competition • 25%

Consumer protection • 25%

Antitrust enforcement • 25%

Big Tech regulation • 25%

Other • 25%

Homelessness • 25%

Crime • 25%

Economic Recovery • 25%

Political Opposition • 25%

Russian military activities • 25%

Terrorism in North Africa • 25%

Cybersecurity threats • 25%

Internal military restructuring • 25%

Autonomous vehicles regulation • 25%

Infrastructure development • 25%

Public transportation enhancement • 25%

Other initiatives • 25%

Highway and bridge reconstruction • 25%

Airport infrastructure improvements • 25%

Public transportation expansion • 25%

Elimination of DEI hiring practices • 25%

Aviation • 25%

Automotive • 25%

Rail and Transit • 25%

Ports and Dams • 25%

Infrastructure rebuilding • 25%

Eliminating DEI practices • 25%

Autonomy economy initiatives • 25%

Other • 25%

Funding Issues • 25%

Public Transport Efficiency • 25%

Environmental Concerns • 25%

Other • 25%

Remains in position • 33%

Resigns • 33%

Removed by administration • 34%

Safety Concerns • 25%

Efficacy Concerns • 25%

Manufacturing Issues • 25%

No Major Issues • 25%